Granuloma Annulare

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2025-04-29
Clinical Trial Update: Tyrosine Kinase 2 (TYK2) for GA and CS [Phase 2]
A Phase 2 trial evaluating a TYK2-targeted therapy for sarcoidosis and granuloma annulare was withdrawn.